| Literature DB >> 18404149 |
David M Goldstein1, Nathanael S Gray, Patrick P Zarrinkar.
Abstract
To fully exploit the potential of kinases as drug targets, novel strategies for the efficient discovery of inhibitors are required. In contrast to the traditional, linear process of inhibitor discovery, high-throughput kinase profiling enables a parallel approach by interrogating compounds against hundreds of targets in a single screen. Compound potency and selectivity are determined simultaneously, providing a choice of targets to pursue that is guided by the quality of lead compounds available, rather than by target biology alone.Mesh:
Substances:
Year: 2008 PMID: 18404149 DOI: 10.1038/nrd2541
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694